{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:58:50Z","timestamp":1771059530840,"version":"3.50.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP1\/233\/46"],"award-info":[{"award-number":["RGP1\/233\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP1\/233\/46"],"award-info":[{"award-number":["RGP1\/233\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11071-4","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:21:51Z","timestamp":1758892911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revolutionizing vaccination: the marvel of nanovaccination technology"],"prefix":"10.1007","volume":"52","author":[{"given":"Rani","family":"Mansuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpit","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Monika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupama","family":"Diwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Shorog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumel","family":"Ashique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Yousuf","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"11071_CR1","first-page":"p 210","volume-title":"Smallpox and its eradication","author":"F Fenner","year":"1987","unstructured":"Fenner F, Henderson DA, Arita I, Je\u017eek Z, Ladnyi ID (1987) Smallpox and its eradication. WHO, Geneva, p p 210"},{"issue":"11","key":"11071_CR2","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/vaccines10111946","volume":"10","author":"R Bezbaruah","year":"2022","unstructured":"Bezbaruah R, Chavda VP, Nongrang L, Alom S, Deka K, Kalita T, Ali F, Bhattacharjee B, Vora L (2022) Nanoparticle-based delivery systems for vaccines. Vaccines 10(11):1946","journal-title":"Vaccines"},{"issue":"4","key":"11071_CR3","doi-asserted-by":"crossref","DOI":"10.3390\/mi12040435","volume":"12","author":"I Menon","year":"2021","unstructured":"Menon I, Bagwe P, Gomes KB, Bajaj L, Gala R, Uddin MN, D\u2019souza MJ, Zughaier SM (2021) Microneedles: a new generation vaccine delivery system. Micromachines 12(4):435","journal-title":"Micromachines"},{"issue":"3","key":"11071_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","volume":"32","author":"L Zhao","year":"2014","unstructured":"Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg AP (2014) Nanoparticle vaccines. Vaccine 32(3):327\u2013337","journal-title":"Vaccine"},{"issue":"8","key":"11071_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","volume":"2","author":"MA Dobrovolskaia","year":"2007","unstructured":"Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat Nanotechnol 2(8):469\u2013478","journal-title":"Nat Nanotechnol"},{"key":"11071_CR6","doi-asserted-by":"publisher","unstructured":"Chavda VP (2019) Nanotherapeutics and nanobiotechnology. In Applications of targeted nano drugs and delivery systems Jan 1 (pp. 1\u201313). Elsevier https:\/\/doi.org\/10.1016\/B978-0-12-814029-1.00001-6","DOI":"10.1016\/B978-0-12-814029-1.00001-6"},{"issue":"10","key":"11071_CR7","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/adfm.201505231","volume":"26","author":"F Wang","year":"2016","unstructured":"Wang F, Fang RH, Luk BT, Hu CM, Thamphiwatana S, Dehaini D, Angsantikul P, Kroll AV, Pang Z, Gao W, Lu W (2016) Nanoparticle-based antivirulence vaccine for the management of methicillin\u2010resistant Staphylococcus aureus skin infection. Adv Funct Mater 26(10):1628\u20131635","journal-title":"Adv Funct Mater"},{"key":"11071_CR8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2017.03.033","volume":"263","author":"M Luo","year":"2017","unstructured":"Luo M, Samandi LZ, Wang Z, Chen ZJ, Gao J (2017) Synthetic nanovaccines for immunotherapy. J Controlled Release 263:200\u2013210","journal-title":"J Controlled Release"},{"key":"11071_CR9","doi-asserted-by":"crossref","unstructured":"Abu-Ramileh R, D'Emanuele A, Attwood D (2005)  Dendrimer-drug interactions. Adv Drug Deliv Rev 57(15):2147\u201362","DOI":"10.1016\/j.addr.2005.09.012"},{"issue":"4","key":"11071_CR10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041106","volume":"15","author":"LA Kisakova","year":"2023","unstructured":"Kisakova LA, Apartsin EK, Nizolenko LF, Karpenko LI (2023) Dendrimer-mediated delivery of DNA and RNA vaccines. Pharmaceutics 15(4):1106","journal-title":"Pharmaceutics"},{"issue":"11","key":"11071_CR11","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q (2021) Lipid nanoparticles from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15(11):16982\u201317015","journal-title":"ACS Nano"},{"issue":"21","key":"11071_CR12","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1021\/ma061019a","volume":"39","author":"Y Haba","year":"2006","unstructured":"Haba Y, Kojima C, Harada A, Kono K (2006) Control of temperature-sensitive properties of poly(amidoamine) dendrimers using peripheral modification with various alkylamide groups. Macromolecules 39(21):7451\u20137453","journal-title":"Macromolecules"},{"key":"11071_CR13","doi-asserted-by":"publisher","unstructured":"Watarai S, Iwase T, Tajima T, Yuba E, Kono K (2013) Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier. Sci World J 2013(1):903234. https:\/\/doi.org\/10.1155\/2013\/903234","DOI":"10.1155\/2013\/903234"},{"key":"11071_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jmmm.2014.10.096","volume":"380","author":"S Chandra","year":"2015","unstructured":"Chandra S, Noronha G, Dietrich S, Lang H, Bahadur D (2015) Dendrimer-magnetic nanoparticles as multiple stimuli responsive and enzymatic drug delivery vehicle. J Magn Magn Mater 380:7\u201312","journal-title":"J Magn Magn Mater"},{"key":"11071_CR15","doi-asserted-by":"publisher","unstructured":"Negut I, Bita B (2023) Polymeric Micellar Systems-A Special Emphasis on \"Smart\" Drug Delivery. Pharmaceutics 15(3):976. https:\/\/doi.org\/10.3390\/pharmaceutics15030976","DOI":"10.3390\/pharmaceutics15030976"},{"issue":"2","key":"11071_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","volume":"21","author":"GS Kwon","year":"1996","unstructured":"Kwon GS, Okano T (1996) Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 21(2):107\u2013116","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"11071_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-3659(97)00040-0","volume":"48","author":"S Cammas","year":"1997","unstructured":"Cammas S, Suzuki K, Sone C, Sakurai Y, Kataoka K, Okano T (1997) Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J Controlled Release 48(1\u20132):157\u2013164","journal-title":"J Controlled Release"},{"issue":"1","key":"11071_CR18","first-page":"35e44","volume":"16","author":"M Nakayama","year":"2006","unstructured":"Nakayama M, Okano T (2006) Intelligent thermoresponsive polymeric micelles for targeted drug delivery. J Drug Deliv Sci Technol 16(1):35e44","journal-title":"J Drug DelivSciTechnol"},{"key":"11071_CR19","doi-asserted-by":"publisher","unstructured":"Dastidar DG, Chakrabarti G (2019) Thermoresponsive drug delivery systems, characterisation and application. App  Target Nano Drug  Delivery Sys. Elsevier, pp 133\u2013155.  https:\/\/doi.org\/10.1016\/B978-0-12-814029-1.00006-5","DOI":"10.1016\/B978-0-12-814029-1.00006-5"},{"key":"11071_CR20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/mabi.201400162","volume":"14","author":"GY Liu","year":"2014","unstructured":"Liu GY, Li M, Zhu CS, Jin Q, Zhang ZC, Ji J (2014) Charge-conversional and pH-sensitive pegylated polymeric micelles as efficient nanocarriers for drug delivery. Macromol Biosci 14:1280\u20131290","journal-title":"Macromol Biosci"},{"key":"11071_CR21","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1016\/j.actbio.2013.05.006","volume":"9","author":"YQ Yang","year":"2013","unstructured":"Yang YQ, Zhao B, Li ZD, Lin WJ, Zhang CY, Guo XD, Wang JF, Zhang LJ (2013) pH-sensitive micelles self-assembled from multi-arm star triblock copolymers poly(\u03b5-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery. Acta Biomater 9:7679\u20137690","journal-title":"Acta Biomater"},{"issue":"3","key":"11071_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2006.11.009","volume":"65","author":"K Letchford","year":"2007","unstructured":"Letchford K, Burt H (2007) A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 65(3):259\u2013269","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"11071_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.01.044","volume":"278","author":"VR Sinha","year":"2004","unstructured":"Sinha VR, Bansal K, Kaushik R, Kumari R, Trepan A (2004) Poly-\u03f5-caprolactone microspheres and nanospheres: an overview. Int J Pharm 278(1):1\u201323","journal-title":"Int J Pharm"},{"key":"11071_CR24","doi-asserted-by":"crossref","unstructured":"Sawutdeechaikul P, Cia F, Bancroft GJ, Wanichwecharungruang S, Sittplangkoon C, Palaga T (2019) Oxidised carbon nanosphere-based subunit vaccine delivery system elicited robust Th1 and cytotoxic T cell responses. J Microbiol Biotechnol 29(3):489-499","DOI":"10.4014\/jmb.1809.09049"},{"key":"11071_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","volume":"303","author":"N Wang","year":"2019","unstructured":"Wang N, Chen M, Wang T (2019) Liposomes used as a vaccine adjuvant-delivery system: from basics to clinical immunisation. J Control Release 303:130\u2013150","journal-title":"J Control Release"},{"issue":"3","key":"11071_CR26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V (2023) An overview of nano structured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull 13(3):446","journal-title":"Adv Pharm Bull"},{"key":"11071_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/389640","volume":"2011","author":"P Shao","year":"2011","unstructured":"Shao P, Wang B, Wang Y, Li J, Zhang Y (2011) The application of thermo sensitivenanocarriers in controlled drug delivery. J Nanomater 2011:1\u201312","journal-title":"J Nanomater"},{"issue":"6","key":"11071_CR28","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1158\/1078-0432.CCR-03-0035","volume":"10","author":"LH Lindner","year":"2004","unstructured":"Lindner LH, Eichhorn ME, Eibl H (2004) Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res 10(6):2168\u20132178","journal-title":"Clin Cancer Res"},{"issue":"6","key":"11071_CR29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/bc050004z","volume":"16","author":"K Kono","year":"2005","unstructured":"Kono K, Murakami T, Yoshida T et al (2005) Temperature sensitisation of liposomes by use of thermo sensitive block copolymers synthesised by living cationic polymerisation: effect of copolymer chain length. Bioconjug Chem 16(6):1367\u20131374","journal-title":"Bioconjug Chem"},{"issue":"3","key":"11071_CR30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0169-409X(01)00204-6","volume":"53","author":"K Kono","year":"2001","unstructured":"Kono K (2001) Thermo sensitive polymer-modified liposomes. Adv Drug Deliv Rev 53(3):307\u2013319","journal-title":"Adv Drug Deliv Rev"},{"issue":"4374","key":"11071_CR31","doi-asserted-by":"crossref","first-page":"1290e3","DOI":"10.1126\/science.364652","volume":"202","author":"MB Yatvin","year":"1978","unstructured":"Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R (1978) Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202(4374):1290e3","journal-title":"Science"},{"issue":"15","key":"11071_CR32","first-page":"3087e94","volume":"35","author":"K Suwa","year":"1997","unstructured":"Suwa K, Morishita K, Kishida A, Akashi M (1997) Synthesis and functionalities of poly(N-vinylalkylamide). V. Control of a lower critical solution temperature of poly(N-vinylalkylamide). J PolymSciPolymChem 35(15):3087e94","journal-title":"J PolymSciPolymChem"},{"key":"11071_CR33","doi-asserted-by":"crossref","unstructured":"Zhao L, Zhu Z, Ma L, Li Y (2020) O\/W nanoemulsion as an adjuvant for an inactivated H3N2 influenza vaccine: based on particle properties and mode of carrying. Int J Nanomed 25:2071\u20132083","DOI":"10.2147\/IJN.S232677"},{"key":"11071_CR34","doi-asserted-by":"crossref","first-page":"101458","DOI":"10.1016\/j.cocis.2021.101458","volume":"54","author":"JS Franklyne","year":"2021","unstructured":"Franklyne JS, Gopinath PM, Mukherjee A, Chandrasekaran N, Nanoemulsions (2021) The rising star of antiviral therapeutics and nanodelivery system\u2014Current status and prospects. Curr Opin Colloid Interface Sci 54:101458","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"11071_CR35","volume":"193","author":"MA Hady","year":"2020","unstructured":"Hady MA, Sayed OM, Akl MA (2020) Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: formulation; optimisation and in-vivo evaluation. Colloids and Surfaces B: Biointerfaces 193:111076","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"11071_CR36","volume":"7","author":"S ScioliMontoto","year":"2020","unstructured":"ScioliMontoto S, Muraca G, Ruiz ME (2020) Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects. Front Mol Biosci 7:319","journal-title":"Front Mol Biosci"},{"key":"11071_CR37","doi-asserted-by":"crossref","unstructured":"Huang M, Zhang M, Zhu H, Du X, Wang J (2022) Mucosal vaccine delivery: A focus on the breakthrough of specific barriers. Acta Pharmaceutica Sinica 12(9):3456\u20133474","DOI":"10.1016\/j.apsb.2022.07.002"},{"issue":"8","key":"11071_CR38","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/pharmaceutics13081135","volume":"13","author":"K Entzian","year":"2021","unstructured":"Entzian K, Aigner A (2021) Drug delivery by ultrasound-responsive nanocarriers for cancer treatment. Pharmaceutics 13(8):1135","journal-title":"Pharmaceutics"},{"key":"11071_CR39","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00602","volume":"8","author":"V Selvarajan","year":"2020","unstructured":"Selvarajan V, Obuobi S, Ee PL (2020) Silica nanoparticles\u2014a versatile tool for the treatment of bacterial infections. Front Chem 8:602","journal-title":"Front Chem"},{"issue":"61","key":"11071_CR40","doi-asserted-by":"crossref","first-page":"35566","DOI":"10.1039\/C9RA06127D","volume":"9","author":"S Mukhopadhyay","year":"2019","unstructured":"Mukhopadhyay S, Veroniaina H, Chimombe T, Han L, Zhenghong W, Xiaole Q (2019) Synthesis and compatibility evaluation of versatile mesoporous silica nanoparticles with red blood cells: an overview. RSC Adv 9(61):35566\u201335578","journal-title":"RSC Adv"},{"issue":"1","key":"11071_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01315-x","volume":"20","author":"RK Kankala","year":"2022","unstructured":"Kankala RK, Han YH, Xia HY, Wang SB, Chen AZ (2022) Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications. J Nanobiotechnol 20(1):1\u201367","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"11071_CR42","doi-asserted-by":"crossref","DOI":"10.3390\/ma12040624","volume":"12","author":"J Simon","year":"2019","unstructured":"Simon J, Flahaut E, Golzio M (2019) Overview of carbon nanotubes for biomedical applications. Materials 12(4):624","journal-title":"Materials"},{"issue":"10","key":"11071_CR43","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.chembiol.2003.10.005","volume":"10","author":"M in het Panhuis","year":"2003","unstructured":"in het Panhuis M (2003) Vaccine delivery by carbon nanotubes. Chem Biol 10(10):897\u2013898","journal-title":"Chem Biol"},{"issue":"2","key":"11071_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cis.2009.05.006","volume":"150","author":"I Capek","year":"2009","unstructured":"Capek I (2009) Dispersions, novel nanomaterial sensors and nanoconjugates based on carbon nanotubes. Adv Colloid Interface Sci 150(2):63\u201389","journal-title":"Adv Colloid Interface Sci"},{"key":"11071_CR45","doi-asserted-by":"crossref","unstructured":"Das C, Paul SS, Saha A, Singh T, Saha A, Im J, Biswas G (2020) Silver-based nanomaterials as therapeutic agents against coronaviruses: a review. Int J Nanomed 23:9301\u20139315","DOI":"10.2147\/IJN.S280976"},{"issue":"4","key":"11071_CR46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4103\/0975-7406.72127","volume":"2","author":"VV Mody","year":"2010","unstructured":"Mody VV, Siwale R, Singh A, Mody HR (2010) Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2(4):282","journal-title":"J Pharm Bioallied Sci"},{"issue":"24","key":"11071_CR47","doi-asserted-by":"crossref","first-page":"13840","DOI":"10.1021\/la9019475","volume":"25","author":"R Sardar","year":"2009","unstructured":"Sardar R, Funston AM, Mulvaney P, Murray RW (2009) Gold nanoparticles: past, present, and future. Langmuir 25(24):13840\u201313851","journal-title":"Langmuir"},{"issue":"31","key":"11071_CR48","doi-asserted-by":"crossref","first-page":"17535","DOI":"10.1021\/acsami.5b05497","volume":"7","author":"S Sungsuwan","year":"2015","unstructured":"Sungsuwan S, Yin Z, Huang X (2015) Lipopeptide-coated iron oxide nanoparticles as potential glycoconjugate-based synthetic anticancer vaccines. ACS Appl Mater Interfaces 7(31):17535\u201317544","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"11071_CR49","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040651","volume":"8","author":"L Powles","year":"2020","unstructured":"Powles L, Wilson KL, Xiang SD, Coppel RL, Ma C, Selomulya C, Plebanski M (2020) Pullulan-coated iron oxide nanoparticles for blood-stage malaria vaccine delivery. Vaccines 8(4):651","journal-title":"Vaccines"},{"issue":"2","key":"11071_CR50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2009.02.010","volume":"136","author":"AK Jain","year":"2009","unstructured":"Jain AK, Goyal AK, Gupta PN, Khatri K, Mishra N, Mehta A, Mangal S, Vyas SP (2009) Synthesis, characterisation and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Controlled Release 136(2):161\u2013169","journal-title":"J Controlled Release"},{"issue":"1","key":"11071_CR51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345(1):41\u201352","journal-title":"N Engl J Med"},{"issue":"1","key":"11071_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.6","volume":"3","author":"MP Manns","year":"2017","unstructured":"Manns MP, Buti M, Gane ED, Pawlotsky JM, Razavi H, Terrault N, Younossi Z (2017) Hepatitis C virus infection. Nat Rev Dis Primers 3(1):1\u20139","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"11071_CR53","first-page":"105","volume":"4","author":"L Singh","year":"2017","unstructured":"Singh L, Kruger HG, Maguire GE, Govender T, Parboosing R (2017) The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis 4(4):105\u2013131","journal-title":"Ther Adv Infect Dis"},{"issue":"12","key":"11071_CR54","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1080\/21645515.2015.1053663","volume":"11","author":"A Farhadian","year":"2015","unstructured":"Farhadian A, Dounighi NM, Avadi M (2015) Enteric trimethyl Chitosan nanoparticles containing hepatitis B surface antigen for oral delivery. Hum Vaccines Immunother 11(12):2811\u20132818","journal-title":"Hum Vaccines Immunother"},{"issue":"1","key":"11071_CR55","first-page":"19","volume":"7","author":"M Nazari","year":"2022","unstructured":"Nazari M, Ebrahimzadeh F, Falaki M, Hajimomeni Y, Varma RS, Fallahnia N (2022) Nanoparticles in the prevention, diagnosis, and treatment of the influenza virus. Nanomed Res J 7(1):19\u201336","journal-title":"Nanomed Res J"},{"issue":"3","key":"11071_CR56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1039\/C8BM01443D","volume":"7","author":"K Ross","year":"2019","unstructured":"Ross K, Senapati S, Alley J, Darling R, Goodman J, Jefferson M, Uz M, Guo B, Yoon KJ, Verhoeven D, Kohut M (2019) Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice. Biomater Sci 7(3):809\u2013821","journal-title":"Biomater Sci"},{"issue":"13","key":"11071_CR57","volume":"14","author":"M Qi","year":"2018","unstructured":"Qi M, Zhang XE, Sun X, Zhang X, Yao Y, Liu S, Chen Z, Li W, Zhang Z, Chen J, Cui Z (2018) Intranasal nanovaccine confers homo-and hetero\u2010subtypic influenza protection. Small 14(13):1703207","journal-title":"Small"},{"issue":"3","key":"11071_CR58","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1021\/acsbiomaterials.5b00477","volume":"2","author":"K Ross","year":"2016","unstructured":"Ross K, Adams J, Loyd H, Ahmed S, Sambol A, Broderick S, Rajan K, Kohut M, Bronich T, Wannemuehler MJ, Carpenter S (2016) Combination nanovaccine demonstrates synergistic enhancement in efficacy against influenza. ACS Biomater Sci Eng 2(3):368\u2013374","journal-title":"ACS Biomater Sci Eng"},{"issue":"8","key":"11071_CR59","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.vaccine.2017.01.019","volume":"35","author":"S Dhakal","year":"2017","unstructured":"Dhakal S, Goodman J, Bondra K, Lakshmanappa YS, Hiremath J, Shyu DL, Ouyang K, Kang KI, Krakowka S, Wannemuehler MJ, Lee CW (2017) Polyanhydridenanovaccine against swine influenza virus in pigs. Vaccine 35(8):1124\u20131131","journal-title":"Vaccine"},{"key":"11071_CR60","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3389\/fimmu.2018.01953","volume":"9","author":"ZR Zacharias","year":"2018","unstructured":"Zacharias ZR, Ross KA, Hornick EE, Goodman JT, Narasimhan B, Waldschmidt TJ, Legge KL (2018) Polyanhydridenanovaccine induces robust pulmonary B and T cell immunity and confers protection against homologous and heterologous influenza A virus infections. Front Immunol 9:1953","journal-title":"Front Immunol"},{"key":"11071_CR61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijbiomac.2021.01.132","volume":"173","author":"P Ding","year":"2021","unstructured":"Ding P, Zhang G, Chen Y, Liu H, Liu Y, Jia R, Wang Y, Li G, Wang A (2021) Reasonable permutation of M2e enhances the effect of universal influenza nanovaccine. Int J Biol Macromol 173:244\u2013250","journal-title":"Int J Biol Macromol"},{"issue":"18","key":"11071_CR62","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1111\/j.1742-4658.2007.05997.x","volume":"274","author":"R Tuteja","year":"2007","unstructured":"Tuteja R (2007) Malaria\u2009\u2013\u2009an overview. FEBS J 274(18):4670\u20134679","journal-title":"FEBS J"},{"issue":"5167","key":"11071_CR63","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1126\/science.8009217","volume":"264","author":"LH Miller","year":"1994","unstructured":"Miller LH, Good MF, Milon G (1994) Malaria pathogenesis. Science 264(5167):1878\u20131883","journal-title":"Science"},{"issue":"3","key":"11071_CR64","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","volume":"167","author":"AF Cowman","year":"2016","unstructured":"Cowman AF, Healer J, Marapana D, Marsh K (2016) Malaria: biology and disease. Cell 167(3):610\u2013624","journal-title":"Cell"},{"issue":"4\u20135","key":"11071_CR65","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","volume":"62","author":"NS Santos-Magalh\u00e3es","year":"2010","unstructured":"Santos-Magalh\u00e3es NS, Mosqueira VC (2010) Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev 62(4\u20135):560\u2013575","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"11071_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-021-03858-0","volume":"20","author":"PB Memvanga","year":"2021","unstructured":"Memvanga PB, Nkanga CI (2021) Liposomes for malaria management: the evolution from 1980 to 2020. Malar J 20(1):1\u201333","journal-title":"Malar J"},{"key":"11071_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2013.10.014","volume":"201","author":"NP Aditya","year":"2013","unstructured":"Aditya NP, Vathsala PG, Vieira V, Murthy RS, Souto EB (2013) Advances in nanomedicines for malaria treatment. Adv Colloid Interface Sci 201:1\u20137","journal-title":"Adv Colloid Interface Sci"},{"issue":"39","key":"11071_CR68","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.vaccine.2015.08.025","volume":"33","author":"R Kumar","year":"2015","unstructured":"Kumar R, Ray PC, Datta D, Bansal GP, Angov E, Kumar N (2015) Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. Vaccine 33(39):5064\u20135071","journal-title":"Vaccine"},{"key":"11071_CR69","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/17425247.5.10.1121","volume":"5","author":"CR Mayer","year":"2008","unstructured":"Mayer CR, Geis NA, Katus HA, Bekeredjian R (2008) Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv 5:1121\u20131138","journal-title":"Expert Opin Drug Deliv"},{"key":"11071_CR70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145\u2013160","journal-title":"Nat Rev Drug Discov"},{"key":"11071_CR71","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1016\/j.biomaterials.2014.05.077","volume":"35","author":"Y Yoshizaki","year":"2014","unstructured":"Yoshizaki Y, Yuba E, Sakaguchi N, Koiwai K, Harada A, Kono K (2014) Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy. Biomaterials 35:8186\u20138196","journal-title":"Biomaterials"},{"key":"11071_CR72","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.biomaterials.2012.12.051","volume":"34","author":"Y Wan","year":"2013","unstructured":"Wan Y, Han J, Fan G, Zhang Z, Gong T, Sun X (2013) Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity. Biomaterials 34:3020\u20133030","journal-title":"Biomaterials"},{"issue":"21","key":"11071_CR73","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1039\/C4NR04249B","volume":"6","author":"Q Hu","year":"2014","unstructured":"Hu Q, Katti PS, Gu Z (2014) Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale 6(21):12273\u201312286","journal-title":"Nanoscale"},{"key":"11071_CR74","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201908_18763","author":"A Facciol\u00e0","year":"2019","unstructured":"Facciol\u00e0 A, Visalli G, Lagan\u00e0 P, La Fauci V, Squeri R, Pellican\u00f2 GF, Nunnari G, Trovato M, Di Pietro A (2019) The new era of vaccines: the nanovaccinology. Eur Rev Med Pharmacol Sci. https:\/\/doi.org\/10.26355\/eurrev_201908_18763","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"18","key":"11071_CR75","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.3390\/nano12183226","volume":"12","author":"V Harish","year":"2022","unstructured":"Harish V, Ansari MM, Tewari D, Gaur M, Yadav AB, Garc\u00eda-Betancourt ML, Abdel-Haleem FM, Bechelany M, Barhoum A (2022) Nanoparticle and nanostructure synthesis and controlled growth methods. Nanomaterials 12(18):3226","journal-title":"Nanomaterials"},{"key":"11071_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112249","volume":"146","author":"DC Soares","year":"2022","unstructured":"Soares DC, Poletto F, Eberhardt MJ, Domingues SC, De Sousa FB, Tebaldi ML (2022) Polymer-hybrid nanosystems for antiviral applications: current advances. Biomed Pharmacother 146:112249","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"11071_CR77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp0804651","volume":"360","author":"CA Arias","year":"2009","unstructured":"Arias CA, Murray BE (2009) Antibiotic-resistant bugs in the 21st century\u2014a clinical super-challenge. N Engl J Med 360(5):439\u2013443","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"11071_CR78","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1038\/nm1226","volume":"11","author":"M Larche","year":"2005","unstructured":"Larche M, Wraith DC (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 11(Suppl 4):S69\u201376","journal-title":"Nat Med"},{"key":"11071_CR79","unstructured":"Joshi VB (2014) Biodegradable particles as vaccine delivery systems. The University of Iowa"},{"key":"11071_CR80","doi-asserted-by":"crossref","unstructured":"Bancos S, Stevens DL, Tyner KM (2015) Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro. Int J Nanomed :183\u2013206","DOI":"10.2147\/IJN.S72580"},{"issue":"9","key":"11071_CR81","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/1535370216643771","volume":"241","author":"E Farris","year":"2016","unstructured":"Farris E, Brown DM, Ramer-Tait AE, Pannier AK (2016) Micro-and nanoparticulates for DNA vaccine delivery. Exp Biol Med 241(9):919\u2013929","journal-title":"Exp Biol Med"},{"key":"11071_CR82","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jconrel.2015.09.046","volume":"219","author":"CJ Bishop","year":"2015","unstructured":"Bishop CJ, Kozielski KL, Green JJ (2015) Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles. J Control Release 219:488\u2013499","journal-title":"J Control Release"},{"key":"11071_CR83","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.2147\/IJN.S178809","volume":"24","author":"S Dhakal","year":"2018","unstructured":"Dhakal S, Cheng X, Salcido J, Renu S, Bondra K, Lakshmanappa YS, Misch C, Ghimire S, Feliciano-Ruiz N, Hogshead B, Krakowka S (2018) Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs. Int J Nanomed 24:6699\u20136715","journal-title":"Int J Nanomed"},{"issue":"5","key":"11071_CR84","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1021\/nn3057005","volume":"7","author":"K Niikura","year":"2013","unstructured":"Niikura K, Matsunaga T, Suzuki T, Kobayashi S, Yamaguchi H, Orba Y, Kawaguchi A, Hasegawa H, Kajino K, Ninomiya T, Ijiro K (2013) Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano 7(5):3926\u20133938","journal-title":"ACS Nano"},{"issue":"2","key":"11071_CR85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/nnm.10.1","volume":"5","author":"T Mamo","year":"2010","unstructured":"Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Langer R, Andrian UV, Farokhzad OC (2010) Emerging nanotechnology approaches for HIV\/AIDS treatment and prevention. Nanomedicine 5(2):269\u2013285","journal-title":"Nanomedicine"},{"issue":"7","key":"11071_CR86","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.vaccine.2014.12.045","volume":"33","author":"MC Hanson","year":"2015","unstructured":"Hanson MC, Abraham W, Crespo MP, Chen SH, Liu H, Szeto GL, Kim M, Reinherz EL, Irvine DJ (2015) Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides. Vaccine 33(7):861\u2013868","journal-title":"Vaccine"},{"issue":"48","key":"11071_CR87","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.vaccine.2016.10.036","volume":"34","author":"E Poteet","year":"2016","unstructured":"Poteet E, Lewis P, Chen C, Ho SO, Do T, Chiang S, Labranche C, Montefiori D, Fujii G, Yao Q (2016) Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV. Vaccine 34(48):5886\u20135894","journal-title":"Vaccine"},{"issue":"10","key":"11071_CR88","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/pharmaceutics11100534","volume":"11","author":"V Vijayan","year":"2019","unstructured":"Vijayan V, Mohapatra A, Uthaman S, Park IK (2019) Recent advances in nano vaccines using biomimetic immunomodulatory materials. Pharmaceutics 11(10):534","journal-title":"Pharmaceutics"},{"key":"11071_CR89","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1208\/s12248-012-9418-6","volume":"15","author":"VB Joshi","year":"2013","unstructured":"Joshi VB, Geary SM, Salem AK (2013) Biodegradable particles as vaccine delivery systems: size matters. AAPS J 15:85\u201394","journal-title":"AAPS J"},{"issue":"1","key":"11071_CR90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-409X(00)00121-6","volume":"47","author":"Y Nishioka","year":"2001","unstructured":"Nishioka Y, Yoshino H (2001) Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 47(1):55\u201364","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"11071_CR91","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1073\/pnas.0910283107","volume":"107","author":"ES Olson","year":"2010","unstructured":"Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, Tsien RY (2010) Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A 107(9):4311\u20136","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"11071_CR92","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jmr.2010.02.003","volume":"204","author":"A Abdine","year":"2010","unstructured":"Abdine A, Verhoeven MA, Park KH, Ghazi A, Guittet E, Berrier C, Van Heijenoort C, Warschawski DE (2010) Structural study of the membrane protein MscL using cell-free expression and solid-state NMR. J Magn Reson 204(1):155\u2013159","journal-title":"J Magn Reson"},{"key":"11071_CR93","doi-asserted-by":"crossref","unstructured":"Zhou Q, Zhang L, Yang T, Wu H (2018) Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomed :2921\u20132942","DOI":"10.2147\/IJN.S158696"},{"key":"11071_CR94","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2741\/s103","volume":"2","author":"SS Venkatraman","year":"2010","unstructured":"Venkatraman SS, Ma LL, Natarajan JV, Chattopadhyay S (2010) Polymer-and liposome-based nanoparticles in targeted drug delivery. Front Biosci (Schol Ed) 2:801\u2013814","journal-title":"Front Biosci (Schol Ed)"},{"issue":"7","key":"11071_CR95","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/10837450.2015.1078353","volume":"21","author":"F Esmaeili","year":"2016","unstructured":"Esmaeili F, Rajabnejhad S, Partoazar AR, Mehr SE, Faridi-Majidi R, Sahebgharani M, Syedmoradi L, Rajabnejhad MR, Amani A (2016) Anti-inflammatory effects of eugenolnanoemulsion as a topical delivery system. Pharm Dev Technol 21(7):887\u2013893","journal-title":"Pharm Dev Technol"},{"issue":"6","key":"11071_CR96","first-page":"257","volume":"7","author":"T Madaan","year":"2015","unstructured":"Madaan T, Pandey S, Talegaonkar S, Delhi N, Nanotechnology (2015) A smart drug delivery tool in modern healthcare. J Chem Pharm Res 7(6):257\u2013264","journal-title":"J Chem Pharm Res"},{"issue":"3","key":"11071_CR97","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/bm301995s","volume":"14","author":"G Lalwani","year":"2013","unstructured":"Lalwani G, Henslee AM, Farshid B, Lin L, Kasper FK, Qin YX, Mikos AG, Sitharaman B (2013) Two- dimensional nanostructure-reinforced biodegradable polymeric nanocomposites for bone tissue engineering. Biomacromolecules 14(3):900\u2013909","journal-title":"Biomacromolecules"},{"issue":"4","key":"11071_CR98","first-page":"15","volume":"1","author":"P Pandey","year":"2016","unstructured":"Pandey P, Dahiya M (2016) Carbon nanotubes: types, methods of preparation and applications. Carbon 1(4):15\u201321","journal-title":"Carbon"},{"issue":"2","key":"11071_CR99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389557520999201116163012","volume":"21","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Usmani Z, Atanasov AG, Singh VK, Singh NP, Abdel-Azeem AM, Prasad R, Gupta G, Sharma M, Bhargava A (2021) Biological nanofactories: using living forms for metal nanoparticle synthesis. Mini Rev Med Chem 21(2):245\u2013265","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"11071_CR100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034226","volume":"7","author":"D Palmberger","year":"2012","unstructured":"Palmberger D, Wilson IB, Berger I, Grabherr R, Rendic D (2012) Sweetbac: a new approach for the production of mammalianised glycoproteins in insect cells. PLoS ONE 7(4):e34226","journal-title":"PLoS ONE"},{"issue":"5","key":"11071_CR101","first-page":"1949","volume":"6","author":"D Goren","year":"2000","unstructured":"Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A (2000) Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res 6(5):1949\u20131957","journal-title":"Clin Cancer Res"},{"issue":"11","key":"11071_CR102","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/smll.200700378","volume":"3","author":"Y Pan","year":"2007","unstructured":"Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W (2007) Size\u2010dependent cytotoxicity of gold nanoparticles. Small 3(11):1941\u20131949","journal-title":"Small"},{"issue":"7","key":"11071_CR103","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/nl901534q","volume":"9","author":"JA Fitzpatrick","year":"2009","unstructured":"Fitzpatrick JA, Andreko SK, Ernst LA, Waggoner AS, Ballou B, Bruchez MP (2009) Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett 9(7):2736\u20132741","journal-title":"Nano Lett"},{"key":"11071_CR104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130754","volume":"265","author":"S Yasmin","year":"2024","unstructured":"Yasmin S, Ansari MY, Pandey K, Dikhit MR (2024) Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach. Int J Biol Macromol 265:130754","journal-title":"Int J Biol Macromol"},{"key":"11071_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107398","volume":"20","author":"S Yasmin","year":"2025","unstructured":"Yasmin S, Ansari MY (2025) A detailed examination of coronavirus disease 2019 (COVID-19): covering past and future perspectives. Microb Pathog 20:107398. https:\/\/doi.org\/10.1016\/j.micpath.2025.107398","journal-title":"Microb Pathog"},{"key":"11071_CR106","doi-asserted-by":"crossref","first-page":"115597","DOI":"10.1016\/j.biopha.2023.115597","volume":"167","author":"MA Abusalah","year":"2023","unstructured":"Abusalah MA, Chopra H, Sharma A, Mustafa SA, Choudhary OP, Sharma M, Dhawan M, Khosla R, Loshali A, Sundriyal A, Saini J (2023) Nanovaccines: A game changing approach in the fight against infectious diseases. Biomed Pharmacother 167:115597","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11071-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:06:34Z","timestamp":1766898394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11071-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11071"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11071-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"949"}}